182
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Mechanisms of Action of Semen Ziziphi spinosae in the Treatment of Tourette Syndrome

ORCID Icon, ORCID Icon &
Pages 85-96 | Published online: 15 Jul 2022

References

  • Robertson MM, Eapen V, Singer HS, et al. Gilles de la Tourette syndrome. Nat Rev Dis Primers. 2017;3(1):16097. doi:10.1038/nrdp.2016.97
  • Scharf JM, Miller LL, Gauvin CA, Alabiso J, Mathews CA, Ben-Shlomo Y. Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov Disord. 2015;30(2):221–228. doi:10.1002/mds.26089
  • Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012;47(2):77–90. doi:10.1016/j.pediatrneurol.2012.05.002
  • Martino D, Johnson I, Leckman JF. What does immunology have to do with normal brain development and the pathophysiology underlying Tourette syndrome and related neuropsychiatric disorders. Front Neurol. 2020;11:567407. doi:10.3389/fneur.2020.567407
  • Conte G, Valente F, Fioriello F, Cardona F. Rage attacks in Tourette syndrome and chronic tic disorder: a systematic review. Neurosci Biobehav Rev. 2020;119:21–36. doi:10.1016/j.neubiorev.2020.09.019
  • Robertson MM. A personal 35 year perspective on Gilles de la Tourette syndrome: prevalence, phenomenology, comorbidities, and coexistent psychopathologies. Lancet Psychiatry. 2015;2(1):68–87. doi:10.1016/S2215-0366(14)00132-1
  • Hirschtritt ME, Lee PC, Pauls DL, et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry. 2015;72(4):325–333. doi:10.1001/jamapsychiatry.2014.2650
  • Cavanna AE, Rickards H. The psychopathological spectrum of Gilles de la Tourette syndrome. Neurosci Biobehav Rev. 2013;37(6):1008–1015. doi:10.1016/j.neubiorev.2012.10.011
  • Virtanen S, Sidorchuk A, Fernández de la Cruz L, et al. Association of Tourette syndrome and chronic tic disorder with subsequent risk of alcohol- or drug-related disorders, criminal convictions, and death: a population-based family study. Biol Psychiatry. 2021;89(4):407–414. doi:10.1016/j.biopsych.2020.09.014
  • Roessner V, Eichele H, Stern JS, et al. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry. 2022;31(3):425–441. doi:10.1007/s00787-021-01899-z
  • Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):896–906. doi:10.1212/WNL.0000000000007466
  • Liu ZS, Cui YH, Sun D, et al. Current status, diagnosis, and treatment recommendation for tic disorders in China. Front Psychiatry. 2020;11:774. doi:10.3389/fpsyt.2020.00774
  • Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):907–915. doi:10.1212/WNL.0000000000007467
  • Huang J, Zhang C, Zhao X, et al. The jujube genome provides insights into genome evolution and the domestication of sweetness/acidity taste in fruit trees. PLoS Genet. 2016;12(12):e1006433. doi:10.1371/journal.pgen.1006433
  • Zhou QH, Zhou XL, Xu MB, et al. suanzaoren formulae for insomnia: updated clinical evidence and possible mechanisms. Front Pharmacol. 2018;9:76. doi:10.3389/fphar.2018.00076
  • Liu Z, Zhao X, Liu B, et al. Jujuboside A, a neuroprotective agent from semen Ziziphi spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ 1–42. Eur J Pharmacol. 2014;738:206–213. doi:10.1016/j.ejphar.2014.05.041
  • Fan F, Hao L, Zhang S, et al. Efficacy of the jingxin zhidong formula for tic disorders: a randomized, double blind, double dummy, parallel controlled trial. Neuropsychiatr Dis Treat. 2022;18:57–66. doi:10.2147/NDT.S347432
  • Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6(1):13. doi:10.1186/1758-2946-6-13
  • Xu X, Zhang W, Huang C, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012;13(6):6964–6982. doi:10.3390/ijms13066964
  • Tian S, Wang J, Li Y, Li D, Xu L, Hou T. The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev. 2015;86:2–10. doi:10.1016/j.addr.2015.01.009
  • Daneman R, Prat A. The blood-brain barrier. Cold Spring Harb Perspect Biol. 2015;7(1):a020412. doi:10.1101/cshperspect.a020412
  • Wang S, Wang H, Lu Y. Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis. Oncotarget. 2017;8(9):14549–14569. doi:10.18632/oncotarget.14675
  • The UniProt Consortium. UniProt: the universal protein knowledgebase [published correction appears in Nucleic Acids Res. Nucleic Acids Res. 2017;45(D1):D158–D169. doi:10.1093/nar/gkw1099
  • Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016;54:1.30.1–1.30.33.
  • Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43:D789–D798. doi:10.1093/nar/gku1205
  • Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613. doi:10.1093/nar/gky1131
  • Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25–29. doi:10.1038/75556
  • Du J, Yuan Z, Ma Z, Song J, Xie X, Chen Y. KEGG-PATH: Kyoto encyclopedia of genes and genomes-based pathway analysis using a path analysis model. Mol Biosyst. 2014;10(9):2441–2447. doi:10.1039/C4MB00287C
  • Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523. doi:10.1038/s41467-019-09234-6
  • Adams PD, Afonine PV, Baskaran K, et al. Announcing mandatory submission of PDBx/mmCIF format files for crystallographic depositions to the Protein Data Bank (PDB). Acta Crystallogr D Struct Biol. 2019;75(Pt 4):451–454. doi:10.1107/S2059798319004522
  • Hu M, Yu Z, Wang J, et al. Traditional uses, origins, chemistry and pharmacology of Bombyx batryticatus: a review. Molecules. 2017;22(10):1779. doi:10.3390/molecules22101779
  • Yang P, Qin Y, Zhu Y, et al. Chaihu-Longgu-Muli decoction relieves epileptic symptoms by improving autophagy in hippocampal neurons. J Ethnopharmacol. 2020;259:112990. doi:10.1016/j.jep.2020.112990
  • Silva AG, Vila L, Marques P, et al. 1-(2’-Bromobenzyl)-6,7-dihydroxy-N-methyl-tetrahydroisoquinoline and 1,2-demethyl-nuciferine as agonists in human D2 dopamine receptors. J Nat Prod. 2020;83(1):127–133. doi:10.1021/acs.jnatprod.9b00921
  • Cao JX, Zhang QY, Cui SY, et al. Hypnotic effect of jujubosides from Semen Ziziphi spinosae. J Ethnopharmacol. 2010;130(1):163–166. doi:10.1016/j.jep.2010.03.023
  • Al-Reza SM, Yoon JI, Kim HJ, Kim JS, Kang SC. Anti-inflammatory activity of seed essential oil from Zizyphus jujuba. Food Chem Toxicol. 2010;48(2):639–643. doi:10.1016/j.fct.2009.11.045
  • Silman I, Sussman JL. Acetylcholinesterase: how is structure related to function? Chem Biol Interact. 2008;175(1–3):3–10. doi:10.1016/j.cbi.2008.05.035
  • Lane RM, Kivipelto M, Greig NH. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin Neuropharmacol. 2004;27(3):141–149. doi:10.1097/00002826-200405000-00011
  • Silveyra MX, Cuadrado-Corrales N, Marcos A, et al. Altered glycosylation of acetylcholinesterase in Creutzfeldt-Jakob disease. J Neurochem. 2006;96(1):97–104. doi:10.1111/j.1471-4159.2005.03514.x
  • Quik M, Zhang D, Perez XA, Bordia T. Role for the nicotinic cholinergic system in movement disorders; therapeutic implications. Pharmacol Ther. 2014;144(1):50–59. doi:10.1016/j.pharmthera.2014.05.004
  • Hildonen M, Levy AM, Dahl C, et al. Elevated expression of SLC6A4 Encoding the Serotonin Transporter (SERT) in Gilles de la Tourette syndrome. Genes. 2021;12(1):86.
  • Gunther J, Tian Y, Stamova B, et al. Catecholamine-related gene expression in blood correlates with tic severity in Tourette syndrome. Psychiatry Res. 2012;200(2–3):593–601. doi:10.1016/j.psychres.2012.04.034
  • Jijun L, Zaiwang L, Anyuan L, et al. Abnormal expression of dopamine and serotonin transporters associated with the pathophysiologic mechanism of Tourette syndrome. Neurol India. 2010;58(4):523–529. doi:10.4103/0028-3886.68663
  • Wendland JR, Moya PR, Kruse MR, et al. A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. Hum Mol Genet. 2008;17(5):717–723. doi:10.1093/hmg/ddm343
  • Moya PR, Wendland JR, Rubenstein LM, et al. Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette’s disorder. Mov Disord. 2013;28(9):1263–1270. doi:10.1002/mds.25460
  • Niesler B, Frank B, Hebebrand J, Rappold G. Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome. Psychiatr Genet. 2005;15(4):303–304. doi:10.1097/00041444-200512000-00015
  • Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol. 2007;1(1):51–60. doi:10.1049/iet-syb:20060032